Cargando…
Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells
BACKGROUND: Neuroblastoma accounts for 7% of paediatric malignancies but is responsible for 15% of all childhood cancer deaths. Despite rigorous treatment involving chemotherapy, surgery, radiotherapy and immunotherapy, the 5-year overall survival rate of high-risk disease remains < 40%, highligh...
Autores principales: | Nile, Donna L., Rae, Colin, Walker, David J., Waddington, Joe Canning, Vincent, Isabel, Burgess, Karl, Gaze, Mark N., Mairs, Robert J., Chalmers, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136224/ https://www.ncbi.nlm.nih.gov/pubmed/34011385 http://dx.doi.org/10.1186/s40170-021-00258-5 |
Ejemplares similares
-
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
por: Nile, Donna L., et al.
Publicado: (2016) -
Preliminary evaluation of prostate‐targeted radiotherapy using (131)I‐MIP‐1095 in combination with radiosensitising chemotherapeutic drugs
por: Tesson, Mathias, et al.
Publicado: (2016) -
Cell cycle specific radiosensitisation by the disulfiram and copper complex
por: Tesson, Mathias, et al.
Publicado: (2017) -
An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with (177)Lu-DOTATATE for the treatment of neuroblastoma
por: Tesson, Mathias, et al.
Publicado: (2018) -
The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
por: Mairs, R. J., et al.
Publicado: (1991)